Postural Orthostatic Tachycardia Syndrome (POTS) is a condition that affects millions of people around the world. It is a condition characterized by an excessive increase in heart rate when a person moves from a lying or sitting position to a standing position. Although it is a relatively common condition, its exact cause is still a mystery. This article will explore the journey of discovery that has been undertaken to uncover the mystery of POTS Syndrome.
POTS Syndrome is a condition that affects the autonomic nervous system, which controls the body's involuntary functions such as heart rate and blood pressure. It is characterized by an excessive increase in heart rate when a person moves from a lying or sitting position to a standing position. This increase in heart rate can be as much as 30 beats per minute or more, and can last for several minutes. Symptoms of POTS Syndrome can include dizziness, lightheadedness, fatigue, difficulty concentrating, headaches, nausea, chest pain, and palpitations. It is estimated that between 1 and 3 million people in the United States alone suffer from POTS Syndrome.
The journey of discovery to uncover the mystery of POTS Syndrome began in the early 1990s when the condition was first identified. Since then, scientists and doctors have been working to uncover the cause of the condition. Early research suggested that it could be caused by an underlying medical condition, such as an autoimmune disorder, or by a problem with the autonomic nervous system. However, it was not until the early 2000s that researchers began to understand the true cause of POTS Syndrome. In 2006, researchers discovered that POTS Syndrome is caused by an abnormality in the autonomic nervous system. Specifically, they found that in people with POTS Syndrome, the autonomic nervous system does not respond appropriately to changes in position. This means that when a person moves from a lying or sitting position to a standing position, the autonomic nervous system does not respond quickly enough, resulting in an excessive increase in heart rate. Since this discovery, researchers have been working to understand why this abnormality occurs in some people and not in others. They have identified several potential causes, including genetic factors, hormonal imbalances, and environmental factors such as stress or dehydration. They have also identified several potential treatments, including lifestyle modifications, medications, and physical therapy.
Postural Orthostatic Tachycardia Syndrome (POTS) is a condition that affects millions of people around the world. Although it is a relatively common condition, its exact cause is still a mystery. Through a journey of discovery, researchers have uncovered the cause of POTS Syndrome and identified potential treatments. As research continues, doctors and scientists hope to uncover more information about the condition and develop more effective treatments.
1.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
2.
Report reveals lung cancer is the leading cause of cancer deaths in Florida
3.
FDA Expands Approval of Osimertinib in Lung Cancer
4.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
5.
Venetoclax Combo Shows Promise in Younger Patients With AML
1.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
2.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
3.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Tumor Microenvironment Readiness as a Predictor of Cancer Progression
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Chemotherapy: What to Expect
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation